Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
(NASDAQ: QTRX) Delayed: 3.49 +0.10 (2.95%)
Previous Close $3.39    52 Week High $ 
Open $3.40    52 Week Low $ 
Day High $3.54    P/E N/A 
Day Low $3.18    EPS $ 
Volume 1,406,797       

StemCells, Inc. (NASDAQ: TEM) Delayed: 47.85 -2.99 (5.88%)
Previous Close $50.84    52 Week High $0.45 
Open $49.75    52 Week Low $0.37 
Day High $51.27    P/E N/A 
Day Low $47.56    EPS $-0.31 
Volume 5,137,623